Affibody AB Employee Directory
Biotechnology ResearchStockholm, Sweden51-200 Employees
Affibody AB is a private Swedish biotechnology company currently in clinical development, pursuing integrated biopharmaceuticals based on its proprietary platforms. The company runs three clinical programs, two of which target psoriasis and B-cell–driven autoimmune diseases, while the third supports a diagnostic imaging program aimed at metastatic breast cancer. It adopts a focused experimental medicine approach and is headquartered in Stockholm. Affibody maintains collaborations with a range of partners, including AbClon, Alexion, Biotest, Daewoong, Daiichi Sankyo, GE Healthcare, and Swedish Orphan Biovitrum. Founded in 1998 by researchers from the Royal Institute of Technology and the Karolinska Institute, Affibody is a holding of Patricia Industries; in 2023 it announced a collaboration with Chiesi Group to develop therapies for respiratory diseases.